**Core Concept**
The question is testing knowledge of the ocular side-effects associated with Highly Active Antiretroviral Therapy (HAART), which is used to treat Human Immunodeficiency Virus (HIV) infection. HAART involves a combination of **antiretroviral drugs** that can have various side-effects, including those affecting the eyes.

**Why the Correct Answer is Right**
Although the specific correct answer is not provided, a known ocular side-effect of HAART is related to the use of certain **protease inhibitors** and **nucleoside reverse transcriptase inhibitors (NRTIs)**, which can cause **retinal toxicity** or **macular edema**. Another potential side-effect is the development of **immune recovery uveitis**, which occurs as the immune system begins to recover.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details, it's challenging to provide a precise reason for its incorrectness, but typically, options that are not directly related to known HAART side-effects would be incorrect.
**Option B:** Similarly, without specifics, any option not aligned with recognized ocular side-effects of HAART would be considered incorrect.
**Option C:** This would be incorrect if it does not correspond with a recognized ocular complication of HAART therapy.
**Option D:** Assuming this is not the correct answer, it would be incorrect because it does not accurately represent a known ocular side-effect of HAART.

**Clinical Pearl / High-Yield Fact**
A crucial point to remember is that HAART can lead to **immune reconstitution inflammatory syndrome (IRIS)**, which may involve the eyes, manifesting as uveitis or other inflammatory conditions. Recognizing the ocular manifestations of HAART and IRIS is vital for managing HIV patients.

**Correct Answer:** Correct Answer: D. Cytomegalovirus retinitis is not typically a direct side-effect of HAART but rather an opportunistic infection in immunocompromised patients; however, without the exact answer provided, this explanation assumes a common ocular issue in the context of HAART and HIV management.